These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 26390560)
1. [THE ROLE OF KALLIKREIN-KININ AND RENIN- ANGIOTENSIN SYSTEM IN THE PATHOGENESIS OF PROSTATE CANCER]. Kogan MI; Chernogubova EA; Chibichjan MB; Macionis AJ; Povilajtite PJ; Matishov DG Urologiia; 2015; (3):50-4. PubMed ID: 26390560 [TBL] [Abstract][Full Text] [Related]
2. Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia. Dinh DT; Frauman AG; Somers GR; Ohishi M; Zhou J; Casley DJ; Johnston CI; Fabiani ME J Pathol; 2002 Feb; 196(2):213-9. PubMed ID: 11793373 [TBL] [Abstract][Full Text] [Related]
3. The kallikrein-kinin and renin-angiotensin systems in the kidney of an African lungfish, Protopterus annectens. Masini MA; Napoli L; Sturla M; Uva B Gen Comp Endocrinol; 1996 Jul; 103(1):93-100. PubMed ID: 8812341 [TBL] [Abstract][Full Text] [Related]
4. [The role of angiotensin-converting enzyme and angiotensin ii receptors of the second type in the pathogenesis of proliferative diseases of the prostate]. Chibichyan MB; Chernogubova EA; Avetyan AV; Lapteva TO; Pavlenko IA; Kogan MI Urologiia; 2022 Mar; (1):5-10. PubMed ID: 35274851 [TBL] [Abstract][Full Text] [Related]
5. Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate. Louis SN; Wang L; Chow L; Rezmann LA; Imamura K; MacGregor DP; Casely D; Catt KJ; Frauman AG; Louis WJ Cancer Detect Prev; 2007; 31(5):391-5. PubMed ID: 18031950 [TBL] [Abstract][Full Text] [Related]
6. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension]. Marzecka J Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117 [TBL] [Abstract][Full Text] [Related]
7. Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems. Su JB J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):319-28. PubMed ID: 23386283 [TBL] [Abstract][Full Text] [Related]
8. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems. Fang C; Schmaier AH Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319 [TBL] [Abstract][Full Text] [Related]
9. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides. Campbell DJ Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095 [TBL] [Abstract][Full Text] [Related]
10. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer. Vallbo C; Wang W; Damber JE BJU Int; 2004 Jun; 93(9):1339-43. PubMed ID: 15180634 [TBL] [Abstract][Full Text] [Related]
11. [The role of the kallikrein-kinin and renin-angiotensin-aldosterone systems in the development of hypertension in glomerulonephritis]. Riabov SI; Kucher AG; Kotovoĭ IuO; Kaiukov IG Klin Med (Mosk); 1990 Dec; 68(12):22-5. PubMed ID: 2084330 [TBL] [Abstract][Full Text] [Related]
12. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score. Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460 [TBL] [Abstract][Full Text] [Related]
13. The role of the renal kallikrein-kinin system in diabetic nephropathy. Riad A; Zhuo JL; Schultheiss HP; Tschöpe C Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):22-6. PubMed ID: 17143067 [TBL] [Abstract][Full Text] [Related]
14. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433 [TBL] [Abstract][Full Text] [Related]
15. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia. Nassis L; Frauman AG; Ohishi M; Zhuo J; Casley DJ; Johnston CI; Fabiani ME J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693 [TBL] [Abstract][Full Text] [Related]
16. [Regulation of prostatic growth, pathogenesis of prostatic adenoma and cancer]. Darenkov AF; Evdokimov VV; Alfimov AE Vestn Ross Akad Med Nauk; 1994; (11):50-9. PubMed ID: 7530531 [TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin and the kallikrein-kinin systems. Campbell DJ Int J Biochem Cell Biol; 2003 Jun; 35(6):784-91. PubMed ID: 12676165 [TBL] [Abstract][Full Text] [Related]
18. Autonomic control in rats with overactivity of tissue renin-angiotensin or kallikrein-kinin system. Ribeiro JM; Santos RA; Pesquero JB; Bader M; Krieger EM Regul Pept; 2005 Jul; 129(1-3):155-9. PubMed ID: 15927711 [TBL] [Abstract][Full Text] [Related]
19. The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction. Schmaier AH Am J Physiol Regul Integr Comp Physiol; 2003 Jul; 285(1):R1-13. PubMed ID: 12793984 [TBL] [Abstract][Full Text] [Related]
20. Cross-talk of the renin-angiotensin and kallikrein-kinin systems. Shen B; El-Dahr SS Biol Chem; 2006 Feb; 387(2):145-50. PubMed ID: 16497145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]